4//SEC Filing
Labinger Barry 4
Accession 0000899243-21-031908
CIK 0001651431other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:05 PM ET
Size
5.6 KB
Accession
0000899243-21-031908
Insider Transaction Report
Form 4
Labinger Barry
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2021-08-04+85,950→ 85,950 totalExercise: $5.09Exp: 2031-08-03→ Common Stock (85,950 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on August 4, 2022 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
Checkmate Pharmaceuticals, Inc.
CIK 0001651431
Entity typeother
Related Parties
1- filerCIK 0001332456
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 4:05 PM ET
- Size
- 5.6 KB